USE OF AT LEAST ONE ISOQUINOLINE COMPOUND OF FORMULA I, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES AND METHOD FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES
The present invention concern the use of isoquinoline alkaloid compounds of formula I in the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases, particularly Alzheimers disease, as well as pharmaceutical composition comprising said compounds and method of treatment of neurodegenerative diseases.wherein R1 is -OH or -OCH3, and X is non-existent, HCl or HBr, including their isomers,